Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

28.980
+1.4205.15%
Volume:17.30K
Turnover:494.10K
Market Cap:3.88B
PE:-26.11
High:29.500
Open:27.600
Low:27.100
Close:27.560
52wk High:33.800
52wk Low:13.480
Shares:134.00M
HK Float Shares:134.00M
Volume Ratio:5.06
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.110
ROE:-27.27%
ROA:-12.63%
PB:5.25
PE(LYR):-26.11
PS:45483.63

Loading ...

Hong Kong Stock Connect Morning Briefing: Fed Rate Hike Expectations Persist, Insurance Funds May Start Buying Hong Kong-Listed ETFs

Stock News
·
Sep 22

Hanx Biopharma, XtalPi Unit Enter Cooperation Contract

MT Newswires Live
·
Sep 21

HanxBio-B and XtalPi Forge Strategic Alliance to Accelerate AI-Driven Drug Discovery

Stock News
·
Sep 21

Hanx Biopharmaceuticals (Wuhan) Enters Agreement to Explore AI for Science in Drug Research

Reuters
·
Sep 21

Hanx Biopharmaceuticals (Wuhan) Co - to Procure Xtalpi Science Platform Services for R&D

THOMSON REUTERS
·
Sep 21

Hanx Biopharmaceuticals (Wuhan) Co - Agreement to Explore AI for Science in Drug R&D and Molecule Design

THOMSON REUTERS
·
Sep 21

Hanxbio 2026 Interim: R&D Costs Down 16.6%, Loss Narrows Slightly as Pipeline Advances

Bulletin Express
·
Sep 21

Hanx Biopharma Plans Capital Raise Through Warrants Offering

MT Newswires Live
·
Sep 14

HANXBIO-B (03378) Announces Plan to Place Up to 13.4 Million Warrants

Stock News
·
Sep 13

Hanx Biopharmaceuticals Proposes Hk$4.82 Million Unlisted Warrant Placing at Hk$0.36 Each

Reuters
·
Sep 13

HanxBio H1 FY26 Loss Narrows to RMB 33.24 Million; Other Income and Gains More than Doubled to RMB 27.61 Million

Reuters
·
Aug 17

Hanx Biopharmaceuticals to Review 1H26 Interim Results at 17 Aug 2026 Board Meeting

Bulletin Express
·
Aug 05

Hanx Biopharmaceuticals Sets Board Meeting to Review Interim Results

Reuters
·
Aug 05

Hanx Biopharma Files HKEX Next-day Disclosure Return on Share Repurchase

Reuters
·
Jul 15

Hanx Biopharmaceuticals repurchases 58,200 H-shares, lifts treasury stock to 2.03 million units

Bulletin Express
·
Jul 14

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure After Share Repurchase

Reuters
·
Jul 14

HANXBIO-B spends HK$1.32 million to buy back 45,700 H-shares, trimming issued float by 0.034%

Bulletin Express
·
Jul 13

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase

Reuters
·
Jul 13

Hanx Biopharma Files HKEX Next-day Return Disclosing Share Buyback at HKD 28.96 Each

Reuters
·
Jul 10

HANXBIO-B spends HK$1.04 million to repurchase 36,400 H-shares, treasury stock rises to 1.88 million shares

Bulletin Express
·
Jul 09